Ozempic Lawsuit Morgan and Morgan Update 2026

If you took Ozempic and ended up with stomach paralysis, a bowel blockage, or sudden vision loss, you probably have questions. Is there a lawsuit? Can you join it? How much could a claim be worth?

Thousands of people are asking the same things. The Ozempic litigation has moved fast, and it is easy to find outdated or exaggerated information online.

This guide explains where the Morgan and Morgan Ozempic lawsuit stands in late September 2026, who may qualify, what the courts have decided, and what to expect next. It is written for patients and families, in plain language. It is general information, not legal advice.

Ozempic Lawsuit Morgan and Morgan Update: Where Things Stand Right Now

Here is the short version as of September 30, 2026:

• No settlement exists. No global settlement or jury verdict has been announced in the federal Ozempic litigation.
• No bellwether trial date is set. The first test trials have not been scheduled.
• A key expert hearing just took place or is wrapping up. Judge Karen Marston scheduled a Rule 702 evidentiary hearing for September 14 to 18, 2026. It decides which scientific experts can testify.
• Two separate federal cases exist. One covers stomach and bowel injuries. The other covers vision loss.
• Filings keep growing. The stomach and bowel MDL has grown to roughly 4,000 pending cases, according to recent trackers.

I could not confirm a written ruling from the September hearing at the time of writing. Check the court’s MDL page or ask your attorney for the latest.

What Is the Morgan and Morgan Ozempic Lawsuit?

Morgan and Morgan is a large U.S. personal injury firm. It was one of the first to sue over GLP-1 drugs.

In August 2023, the firm filed a federal case for a Louisiana woman, Jaclyn Bjorklund. She alleged Novo Nordisk and Eli Lilly failed to warn patients about serious digestive injuries linked to Ozempic and Mounjaro. At that time, the firm said it had been retained by more than 500 people across 45 states.

That single case helped set off a wave of filings. Similar cases were later consolidated into a federal multidistrict litigation.

Today, “the Morgan and Morgan Ozempic lawsuit” usually means one of two things:

1. The firm’s role as a court-appointed leader of the national GLP-1 case.
2. Individual claims the firm files for clients inside that case.

Morgan and Morgan attorney Paul Pennock and colleagues took leadership roles in the litigation. The firm sits alongside other leading plaintiff firms, including Seeger Weiss, Wagstaff & Cartmell, and Motley Rice.

Read More: Chicken Class Action Lawsuit 2026: Payouts and Deadlines

The Core Allegation

The claims share one theory: the drugmakers knew, or should have known, that GLP-1 medications could cause severe injuries, yet did not warn patients and doctors clearly enough.

This is called a failure to warn claim. It does not say the drug should never exist. It says people deserved honest information before taking it.

Ozempic Lawsuit Update 2026: What Has Changed This Year

Several things shifted in 2026.

• Case counts climbed. The stomach and bowel MDL passed 3,600 cases in spring and neared 4,000 by summer.
• Expert phase began. Expert reports, depositions, and motions to exclude experts dominated the first half of the year.
• Science Day for vision cases. The judge held or scheduled a Science Day so both sides could explain the science on vision loss.
• New vision loss filings. Plaintiffs continue to file NAION cases. A Massachusetts man filed one as recently as this week.
• FDA pressure on Novo Nordisk. In March 2026, the FDA sent Novo Nordisk a warning letter over safety reporting. It said three deaths were not reported on time. This is not a ruling on the lawsuits, but plaintiffs may point to it.
• Wrongful death claims. A lawsuit filed in March 2026 alleged a 76-year-old woman died after developing gastroparesis.
• Hearing date moved. The Rule 702 hearing was shifted to September 14 to 18.

What Has Not Changed

• No settlement.
• No trial.
• The U.S. Ozempic label, as of mid-2026, still does not carry a specific NAION vision warning. Europe added NAION as a “very rare” side effect in June 2025.

Ozempic MDL 2026: Understanding the Multi-District Litigation

An MDL, or multidistrict litigation, gathers similar federal lawsuits from across the country into one court. This avoids duplicate work and inconsistent rulings on shared issues.

The Two Ozempic MDLs

Feature	MDL 3094	MDL 3163
Injuries	Gastroparesis, ileus, bowel obstruction, and related GI harm	NAION and sudden vision loss
Created	February 2024	December 2025
Court	Eastern District of Pennsylvania	Eastern District of Pennsylvania
Judge	Karen S. Marston	Karen S. Marston
Size	About 4,000 cases	Roughly 110 to 130+ cases
Defendants	Novo Nordisk, Eli Lilly	Novo Nordisk, Eli Lilly

The original judge, Gene Pratter, died in 2024. Judge Marston took over.

How an MDL Works

Each person keeps an individual case. Only the early phase is shared. That phase usually includes:

1. Filing and consolidation
2. Shared discovery (documents and depositions)
3. Science Day
4. Motions to dismiss
5. Expert challenges (Daubert or Rule 702)
6. Bellwether trials
7. Settlement talks or remand to home courts

Right now, MDL 3094 is at step five.

Key Rulings So Far

In August 2025, Judge Marston largely denied the drugmakers’ motion to dismiss. But she also narrowed the case. Reports say she struck some claims, including design defect theories tied to FDA preemption and medical monitoring. She also criticized some negligence claims as too broad.

Her most important ruling for patients came next, on how gastroparesis must be proven. More on that below.

Ozempic Bellwether Trial 2026: What to Expect

A bellwether trial is a test case. The court picks a small group of representative claims and tries them before a jury. The results show both sides how jurors may react.

Current Status

• No bellwether date has been set.
• Earlier predictions of trials in early or mid 2026 did not happen.
• Most analysts now see 2027 as more realistic, if the case survives the expert rulings.

Why the September Hearing Matters

The Rule 702 hearing tests whether plaintiffs’ experts can tell a jury that GLP-1 drugs cause these injuries. It also covers warning adequacy and preemption, which is a defense argument that federal law blocks state claims.

Three outcomes are possible:

• Plaintiffs win most rulings. The case moves toward bellwether selection.
• Split outcome. Some injuries or theories go forward, others fall away.
• Defense wins broadly. The litigation could shrink sharply.

I cannot predict which one will happen. Be wary of any site that promises a result.

What Happens After Rulings

If claims survive, the judge and lawyers choose a pool of cases. Each side may strike some. A few go to trial. Verdicts, good or bad, often drive settlement talks.

Who Qualifies for the Ozempic Lawsuit?

You may qualify if you meet most of these conditions:

• You were prescribed and used Ozempic (semaglutide) or a related GLP-1 drug.
• You suffered a serious injury after starting it.
• A doctor diagnosed that injury.
• You have medical records connecting your use and your condition.
• You are still within your state’s filing deadline.

Related drugs also appear in the litigation, including Wegovy, Rybelsus, Mounjaro, and Zepbound.

Who Usually Does Not Qualify

• People with only mild, short-lived nausea or diarrhea
• People whose condition began long before taking the drug
• People who never took a prescription GLP-1 product
• People whose only proof is a self-diagnosis

Milder side effects are known and listed on the label. Lawsuits focus on serious, lasting harm.

Ozempic Eligibility Requirements: The Specific Details

Law firms screen cases in detail. These are the items that matter most.

For Stomach and Bowel Claims (MDL 3094)

1. Proof of GLP-1 use. Pharmacy records, prescriptions, or insurance claims.
2. A qualifying diagnosis. Gastroparesis, ileus, intestinal obstruction, or a related condition.
3. Objective testing. For gastroparesis, a gastric emptying study is now expected.
4. Timing. Symptoms began during use or soon after.
5. Treatment history. ER visits, hospital stays, feeding tubes, or surgery strengthen claims.

For Vision Claims (MDL 3163)

1. Proof of semaglutide use
2. A diagnosis of NAION by an eye specialist
3. Records showing when vision changed
4. Details about other risk factors, such as diabetes, high blood pressure, or sleep apnea

Documents to Gather

• Prescription and pharmacy records
• Medical records and test results
• Hospital bills
• Photos or notes tracking symptoms
• Work loss records
• A short timeline of your health history

Doing this early saves time, even if you decide not to file.

Ozempic Gastroparesis Lawsuit: The Most Common Injury Claim

Gastroparesis is often called stomach paralysis. The stomach empties too slowly. Food sits and causes trouble.

Common Symptoms

• Ongoing nausea
• Repeated vomiting
• Bloating and early fullness
• Stomach pain
• Weight loss and malnutrition
• Dehydration

The Legal Issue

Plaintiffs argue that semaglutide slows gastric emptying and can push some people into a lasting condition. Novo Nordisk points out that delayed emptying is a known drug effect and that labels already discuss GI events. It has said most GI side effects are mild to moderate and short-lived.

The Gastric Emptying Study Rule

In August 2025, Judge Marston ruled that people claiming gastroparesis need results from a properly done gastric emptying study. Symptoms alone are not enough.

This matters because many patients were diagnosed by symptoms only. If you never had the test, you may still have another qualifying injury. A lawyer can advise you.

Why This Ruling Helps Some Cases

It filters out weak claims. Plaintiffs with strong test results may be better positioned when bellwether cases are chosen.

Ozempic Intestinal Obstruction Lawsuit: The Second Major Injury Category

The second group involves ileus and bowel obstruction. In these conditions, the intestines fail to move contents along, or something blocks the path.

Warning Signs

• Severe belly pain and swelling
• Vomiting that will not stop
• No bowel movements or gas
• Hard, distended abdomen

This can be a medical emergency. Seek care right away if you have these signs.

Label History

In September 2023, the FDA added an ileus warning to the Ozempic label. Plaintiffs say this was late and came after harm had already occurred. The manufacturer says GI events are well known in this drug class.

Why It Matters

Ileus is now on the label, which can affect claims in two ways. Cases from before the warning may look stronger on the failure to warn theory. Cases after it may face the argument that patients were told. Timing of your use may matter a lot.

Ozempic Side Effects Lawsuit: What Conditions Are Covered

The list of injuries in the litigation is wider than most people expect.

Digestive conditions (MDL 3094):

• Gastroparesis
• Ileus
• Intestinal obstruction
• Severe pancreatitis
• Gallbladder disease, including gallstones and cholecystitis
• Other serious GI complications

Vision conditions (MDL 3163):

• NAION, a sudden loss of blood flow to the optic nerve, often causing permanent vision loss

Other claims in the news:

• Aspiration during anesthesia
• Kidney injury
• Thyroid cancer allegations
• Wrongful death

Not all of these have the same legal strength. Some are in the MDLs. Others are earlier stage, or filed in state courts.

Common Side Effects That Do Not Usually Support a Case

Mild nausea, short-term diarrhea, or constipation that resolved are listed on the label. They rarely support a lawsuit alone.

Novo Nordisk Ozempic Lawsuit: Who Is Being Sued

The main defendant is Novo Nordisk, the Danish company that makes Ozempic, Wegovy, and Rybelsus.

Eli Lilly is also named. It makes Mounjaro and Zepbound, which contain tirzepatide.

What Plaintiffs Say Novo Nordisk Did Wrong

• Did not warn adequately about GI injuries
• Did not warn about vision loss risk
• Marketed the drug widely while downplaying risks
• Delayed label changes

What Novo Nordisk Says

• Ozempic is safe and effective when used as directed
• GI effects are known and listed
• NAION has not been shown to be caused by semaglutide, according to the company’s assessment
• Underlying health conditions explain many injuries

Doctors are generally not the target of these claims. Lawsuits say the manufacturer failed to give doctors the right information.

Ozempic Class Action vs Mass Tort: What Is the Difference

People often say “class action” when they mean something else. The Ozempic cases are not a class action.

Feature	Class Action	Mass Tort / MDL
Plaintiffs	One group represented by a few named people	Each person is a separate plaintiff
Damages	Same formula for all	Based on each person’s injury
Best for	Similar small losses	Serious, varied injuries
Your control	Limited	More control
Typical payout	Small, equal shares	Varies widely

Why Ozempic Is a Mass Tort

Injuries differ a lot. A person with a feeding tube has a different claim than someone with a resolved blockage. Courts treat these as individual cases with shared early steps.

If you see a website advertising an “Ozempic class action,” read it carefully. It is usually a marketing term for the MDL.

Ozempic Lawsuit Settlement Amount: What Could Cases Be Worth

Here is the honest answer: nobody knows yet.

No settlement has been announced. Any number you see today is an estimate, and many are guesses.

What Drives Value in Drug Injury Cases

• Severity and permanence of the injury
• Medical costs, past and future
• Lost income
• Strength of proof, especially testing
• Age and life impact
• Whether the drug clearly caused the harm
• State law, which affects damages

How Settlements Usually Work

In large MDLs, defendants often negotiate a global deal after bellwether trials. A points system may rank each claim. Plaintiffs who meet the requirements get a share.

A Word of Caution

Some sites list big ranges to attract clicks. Treat those with skepticism. Real settlements can take years, and cases can end with nothing if experts are excluded or defenses succeed.

Ozempic Lawsuit Payout Per Person: Realistic Expectations

Because no deal exists, there is no official payout per person.

What we can say:

• Payouts will not be equal. A mild claim gets less than a severe permanent one.
• Fees and costs come out first. Most firms, including Morgan and Morgan, work on contingency. You typically pay nothing unless there is a recovery, but fees and case costs are taken from the result. Ask about the exact percentage.
• Liens may apply. Health insurers and Medicare may seek repayment.
• Timing is long. Many drug MDLs take several years from filing to payment.
• Not every claim is paid. Some cases are dismissed.

A Better Question

Instead of “How much will I get?”, ask:

1. Is my injury documented and serious?
2. Do I have the tests the court expects?
3. Is my deadline near?

Those factors shape your outcome more than headlines do.

Ozempic Lawsuit Compensation: What You Can Claim

If a case succeeds, compensation usually falls into these groups.

Economic Damages

• Hospital and doctor bills
• Medications and treatments
• Feeding tubes and surgery
• Future medical care
• Lost wages
• Lost earning ability

Non-Economic Damages

• Pain and suffering
• Emotional distress
• Loss of enjoyment of life
• Disfigurement or lasting disability

Wrongful Death Damages

If a loved one died, family members may claim:

• Funeral and burial costs
• Loss of income and support
• Loss of companionship

Punitive Damages

In rare cases, a jury may add punitive damages to punish extreme misconduct. These are hard to win and depend on state law.

Ozempic Lawsuit Statute of Limitations: Do Not Miss the Deadline

A statute of limitations is the legal deadline to file. Miss it, and your claim may be barred, even if your injury is real.

How It Works

• Deadlines are set by state law.
• They can be as short as one year in some states and longer in others.
• Many states use a discovery rule. The clock starts when you knew, or should have known, that the drug may have caused your injury.
• Deadlines for wrongful death often run from the date of death.
• Minors may get extra time.

Practical Tips

1. Write down when symptoms began.
2. Write down when a doctor first linked them to the drug, if ever.
3. Do not assume you have years left.
4. Talk to a lawyer soon, even if you are unsure.

Because the MDL is large, joining does not mean filing is urgent for everyone. But waiting can put your claim at risk. Getting a case review is free at most firms.

How to File an Ozempic Lawsuit: Step by Step

1. Get medical care first. Your health comes first. Follow your doctor’s advice about the drug.
2. Collect your records. Prescriptions, pharmacy history, diagnoses, test results, and bills.
3. Write a timeline. Note when you started the drug, when symptoms began, and major events.
4. Request testing if advised. If your doctor suspects gastroparesis, a gastric emptying study may matter. Do this for medical reasons, not just legal ones.
5. Speak with an attorney. Ask about experience, fees, and expectations.
6. Sign a retainer. This is the agreement with the firm.
7. Case is filed or registered. Your lawyer files in the MDL or a proper court.
8. Complete the plaintiff fact sheet. This form gives detailed medical and usage history. Vision cases are now facing these deadlines.
9. Discovery and review. The defense may request records or depositions.
10. Wait for court steps. This includes expert rulings, bellwethers, and possible settlement.

Do not stop a prescribed medication without talking to your doctor.

Morgan and Morgan Ozempic Case Evaluation: What to Expect

If you contact Morgan and Morgan, the process typically looks like this.

Step 1: Free Consultation

You share basic facts by phone or online form. There is normally no cost to ask.

Step 2: Screening Questions

Expect questions like:

• Which GLP-1 drug did you take?
• Dates of use and dose?
• What injury do you have?
• Who diagnosed it?
• Did you have a gastric emptying study or eye exam?
• Where do you live?

Step 3: Records Review

If you appear to qualify, the firm asks for records or helps get them.

Step 4: Decision

The firm tells you whether it will take the case. You are not obligated to sign.

Step 5: Ongoing Communication

If retained, you should get updates as the MDL moves forward.

Questions to Ask Any Firm

• What percentage is your fee?
• Who pays case costs if we lose?
• Who will handle my case day to day?
• How will you keep me updated?
• How will my injury be categorized?

Be careful with cold calls or ads that seem to push you to sign right away. Choose a firm you trust.

Frequently Asked Questions

Is there an Ozempic settlement yet?

No. As of September 2026, no global settlement or verdict has been announced.

Is Morgan and Morgan handling Ozempic lawsuits?

Yes. The firm is a court-appointed co-lead firm in the federal GLP-1 litigation and files cases for clients.

When is the first Ozempic trial?

No bellwether date is set. Most experts expect 2027 at the earliest, depending on expert rulings.

What is MDL 3094?

It is the federal case in Pennsylvania covering GLP-1 stomach and bowel injuries, led by Judge Karen Marston.

What is MDL 3163?

It is a separate federal proceeding for GLP-1 vision loss claims, especially NAION.

Do I need a gastric emptying study to file?

For gastroparesis claims, the court now expects one. Other injuries may not need it.

Can I sue if I took Ozempic for weight loss instead of diabetes?

Yes, off-label use does not automatically bar a claim, though it can be raised as a defense issue.

Is the Ozempic lawsuit a class action?

No. It is a mass tort, where each person has an individual claim.

How much does it cost to hire Morgan and Morgan?

Firms like this typically use contingency fees, meaning no upfront fee. Ask for the exact terms in writing.

What is the deadline to file?

It depends on your state. It can be as short as one year, so speak with a lawyer soon.

Should I stop taking Ozempic if I am injured?

Talk to your doctor first. Do not stop or change medication on your own.

Does the FDA label warn about vision loss?

As of mid-2026, the U.S. label does not include a specific NAION warning. Europe added one in 2025.

Conclusion

The Ozempic lawsuit is real, large, and still unfolding. Morgan and Morgan helped start it and now helps lead it. Thousands of people have filed claims for gastroparesis, bowel blockage, and vision loss.

But the honest truth is that it is still early. There is no settlement, no verdict, and no trial date. The September 2026 expert hearing may shape what happens next.

If you were seriously hurt after taking Ozempic, here is what to do now:

• Get proper medical care.
• Save every record.
• Understand your state’s deadline.
• Talk to an attorney who will explain your options honestly.

Do not rely on payout charts or promises. Focus on documenting your injury and protecting your right to file.